We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Artificial Peptides Block Infectivity of Influenza Virus

News   Sep 29, 2017 | Original story from The Scripps Research Institute (TSRI)

 
Artificial Peptides Block Infectivity of Influenza Virus

The Janssen and TSRI teams designed and characterized a potent peptide that mimicked the functionality of a broadly neutralizing antibody and which was also able to target influenza virus hemagglutinin. Image credit: Rameshwar U. Kadam (Ian Wilson's Lab)

 
 
 

RELATED ARTICLES

Shortcut to Recreating Key HIV Antibody for Vaccines

News

A portion of the roadmap toward effective neutralization of HIV has been clarified, identifying the steps that a critical HIV antibody takes to develop and maintain its ability to neutralize the virus.

READ MORE

A Sobering Conclusion: Adult Hearts Do Not Contain Stem Cells

News

While cardiac stem cells (CSC) are of great interest for regenerative intervention, the significance of these populations remains heavily debated. A study published in PNAS did not find any evidence for the existence of a quiescent CSC population.

READ MORE

Drug Cocktail Cripples Cancer Cells

News

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE